These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38479160)

  • 1. Cancer-associated fibroblasts promote gastric cancer cell proliferation by paracrine FGF2-driven ribosome biogenesis.
    Li D; Huang P; Xia L; Leng W; Qin S
    Int Immunopharmacol; 2024 Apr; 131():111836. PubMed ID: 38479160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling.
    Suh J; Kim DH; Lee YH; Jang JH; Surh YJ
    Mol Carcinog; 2020 Sep; 59(9):1028-1040. PubMed ID: 32557854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer.
    Li X; Sun Z; Peng G; Xiao Y; Guo J; Wu B; Li X; Zhou W; Li J; Li Z; Bai C; Zhao L; Han Q; Zhao RC; Wang X
    Theranostics; 2022; 12(2):620-638. PubMed ID: 34976204
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and characterization of FGFR2
    Qiu H; Zhang X; Qi J; Zhang J; Tong Y; Li L; Fu L; Qin YR; Guan X; Zhang L
    J Exp Clin Cancer Res; 2022 Aug; 41(1):240. PubMed ID: 35941662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
    Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
    Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cancer-associated fibroblast-related signature predicts prognosis and indicates immune microenvironment infiltration in gastric cancer.
    Mak TK; Li X; Huang H; Wu K; Huang Z; He Y; Zhang C
    Front Immunol; 2022; 13():951214. PubMed ID: 35967313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H. pylori-induced NF-κB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling.
    Chen B; Liu X; Yu P; Xie F; Kwan JSH; Chan WN; Fang C; Zhang J; Cheung AHK; Chow C; Leung GWM; Leung KT; Shi S; Zhang B; Wang S; Xu D; Fu K; Wong CC; Wu WKK; Chan MWY; Tang PMK; Tsang CM; Lo KW; Tse GMK; Yu J; To KF; Kang W
    Clin Transl Med; 2023 Nov; 13(11):e1481. PubMed ID: 37983931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of miRNA-214 in cancer-associated fibroblasts contributes to migration and invasion of gastric cancer cells through targeting FGF9 and inducing EMT.
    Wang R; Sun Y; Yu W; Yan Y; Qiao M; Jiang R; Guan W; Wang L
    J Exp Clin Cancer Res; 2019 Jan; 38(1):20. PubMed ID: 30646925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone Receptor Signaling Promotes Cancer Associated Fibroblast Mediated Tumorigenicity in ER+ Breast Cancer.
    Diep CH; Spartz A; Truong TH; Dwyer AR; El-Ashry D; Lange CA
    Endocrinology; 2024 Jul; 165(9):. PubMed ID: 39041201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells toward Breast Tumor Progression.
    Santolla MF; Vivacqua A; Lappano R; Rigiracciolo DC; Cirillo F; Galli GR; Talia M; Brunetti G; Miglietta AM; Belfiore A; Maggiolini M
    Cells; 2019 Mar; 8(3):. PubMed ID: 30866584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated single-cell and bulk RNA sequencing analysis identifies a cancer-associated fibroblast-related gene signature for predicting survival and therapy in gastric cancer.
    Zhou Z; Guo S; Lai S; Wang T; Du Y; Deng J; Zhang S; Gao G; Zhang J
    BMC Cancer; 2023 Jan; 23(1):108. PubMed ID: 36717783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development.
    Huang C; Liu J; He L; Wang F; Xiong B; Li Y; Yang X
    Bioengineered; 2021 Dec; 12(2):11738-11755. PubMed ID: 34895039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblast-secreted IGFBP7 promotes gastric cancer by enhancing tumor associated macrophage infiltration via FGF2/FGFR1/PI3K/AKT axis.
    Li D; Xia L; Huang P; Wang Z; Guo Q; Huang C; Leng W; Qin S
    Cell Death Discov; 2023 Jan; 9(1):17. PubMed ID: 36681667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single cell and bulk RNA sequencing identifies tumor microenvironment subtypes and chemoresistance-related IGF1
    Jia X; Li Z; Zhou R; Feng W; Yi L; Zhang H; Chen B; Li Q; Huang S; Zhu X
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167123. PubMed ID: 38484940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine protease PRSS23 drives gastric cancer by enhancing tumor associated macrophage infiltration
    Qin S; Wang Z; Huang C; Huang P; Li D
    Front Immunol; 2022; 13():955841. PubMed ID: 36189305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdissection of cancer-associated fibroblast infiltration subtypes unveils the secreted SERPINE2 contributing to immunosuppressive microenvironment and immuotherapeutic resistance in gastric cancer: A large-scale study integrating bulk and single-cell transcriptome profiling.
    Zhang D; Sun R; Di C; Li L; Zhao F; Han Y; Zhang W
    Comput Biol Med; 2023 Nov; 166():107406. PubMed ID: 37729702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-cell and bulk RNA sequencing reveal cancer-associated fibroblast heterogeneity and a prognostic signature in prostate cancer.
    Liu W; Wang M; Wang M; Liu M
    Medicine (Baltimore); 2023 Aug; 102(32):e34611. PubMed ID: 37565899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer.
    Ham IH; Oh HJ; Jin H; Bae CA; Jeon SM; Choi KS; Son SY; Han SU; Brekken RA; Lee D; Hur H
    Mol Cancer; 2019 Mar; 18(1):68. PubMed ID: 30927911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting the GAS6/AXL axis suppresses tumor progression by blocking the interaction between cancer-associated fibroblasts and cancer cells in gastric carcinoma.
    Bae CA; Ham IH; Oh HJ; Lee D; Woo J; Son SY; Yoon JH; Lorens JB; Brekken RA; Kim TM; Han SU; Park WS; Hur H
    Gastric Cancer; 2020 Sep; 23(5):824-836. PubMed ID: 32239298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periostin secreted by cancer-associated fibroblasts promotes cancer progression and drug resistance in non-small cell lung cancer.
    Takatsu F; Suzawa K; Tomida S; Thu YM; Sakaguchi M; Toji T; Ohki M; Tsudaka S; Date K; Matsuda N; Iwata K; Zhu Y; Nakata K; Shien K; Yamamoto H; Nakayama A; Okazaki M; Sugimoto S; Toyooka S
    J Mol Med (Berl); 2023 Dec; 101(12):1603-1614. PubMed ID: 37831111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.